Bayer and Onyx announce pivotal Nexavar kidney cancer study

Armen Hareyan's picture
Advertisement

Kidney Cancer Treatment

Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the New England Journal of Medicine has published their pivotal Phase III trial demonstrating that Nexavar

Advertisement